Exclusive Invitation: Franklin Women’s ‘Making Career Moves’ Series

Health Industry Hub is thrilled to extend an exclusive invitation to those who registered for Franklin Women’s transformative 5-part series on Making Career Moves, welcoming you into our vibrant community.

For researchers and academics considering a career transition to the pharma, medtech, diagnostics or biotech industry, Health Industry HubTM is the only one-stop-hub that connects you to:

Breaking news across the pharma, medtech, diagnostics and biotech sectors to keep you informed of the evolving healthcare sector trends and dynamics.

Webinars and podcasts with industry leaders and influencers highlighting key themes in policy & advocacy, medical & surgical innovations, digital health, company culture, health equity, sustainability and more.

Health Industry Hub Awards 2023 which recognises remarkable individuals and organisations that inspire us to challenge the status quo and embark on a purposeful journey to reimagine healthcare.

Why?

As the founder of Health Industry Hub, Rozalina Sarkezians brings a diverse background as a health professional with two decades of rich experience in the pharmaceutical and diagnostics sectors. Having served as a panellist in the final webinar of Franklin Women’s 5-part series on Making Career Moves, she is passionate about guiding and supporting individuals who are considering a career move to industry or as an entrepreneur. This dedication is exemplified through her mentorship of IMNIS PhD students and William Clarke College students over the past few years.

Exclusive Invitation: Valid to 26 October 2023

The annual subscription has been discounted from $327.80 to $200, exclusively tailored for Making Career Moves series attendees. Upon subscribing below, your account will be set up and a confirmation email sent to you with your login details.

A tax invoice will be emailed to you, should you wish to claim this professional development investment from your employer or during your annual tax return. By continuing, you agree to our privacy policy and accept our terms & conditions. If you require assistance with your subscription, connect with us here.

News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.